Austria Medication Assisted Therapy (MAT) Market to 2032
Overview
The Austria Medication Assisted Therapy (MAT) Market is expected to reach a 60.49 by 2032 and is projected to grow at a CAGR of 9.05% from 2025 to 2032.
Revenue, 2024 ()
38.30
Forecast, 2032 ()
60.49
CAGR, 2024 - 2032
9.05%
Report Coverage
Austria
Austria Medication Assisted Therapy (MAT) Market 2018-2032
Austria Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 38.30
- Projected Market Size (2032): 60.49
- CAGR (2025-2032): 9.05%
Key Findings of Austria Medication Assisted Therapy (MAT) Market
- The Austria Medication Assisted Therapy (MAT) Market was valued at 38.30 in 2024.
- The Austria Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 9.05% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 36.61
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 11.49% during the forecast period from 2024 to 2032.
Austria Medication Assisted Therapy (MAT) Market Scope
Austria Medication Assisted Therapy (MAT) Market Segmentation & Scope
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Type
- Therapy
- Medication
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Austria Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 38.30 |
| Market Value in 2032 | 60.49 |
| CAGR (2025-2032) | 9.05% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Type,Drug Type,Dosage Form,Route of Administration,Population Type,Products |
Regional Insights:
-
Leading Market (2024-2032): Austria, leading in terms of revenue 38.30 in 2024
- Key Country: Austria, leading in terms of revenue with value of 38.30 in 2024.
Segments and Scope
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 11.39 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.58 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 16.21 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.25 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 21.38 in the year 2024.
- Medication is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.72 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 19.09 in the year 2024.
- Generics is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.93 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 13.04 in the year 2024.
- Immediate Release is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.28 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 12.23 in the year 2024.
- Oral is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.44 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 36.61 in the year 2024.
- Adults is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 9.12 % in forecast period 2025-2032.
-
Austria Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 5.14 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in Austria Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.49 % in forecast period 2025-2032.
Austria Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
Austria Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
Austria Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Austria Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Distribution Channel,End User,Type,Drug Type,Dosage Form,Route of Administration,Population Type,Products.
Austria Medication Assisted Therapy (MAT) Market was valued at USD 38.30(Revenue in ) in 2020.
Austria Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 9.05% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Austria Medication Assisted Therapy (MAT) Market, holding a largest market share of 36.61 in 2024
Coming Soon....
Austria Medication Assisted Therapy (MAT) Market Scope
Austria Medication Assisted Therapy (MAT) Market Segmentation & Scope
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Type
- Therapy
- Medication
Drug Type
- Branded
- Generics
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Population Type
- Teenage
- Adults
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Frequently Asked Questions
The Austria Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Distribution Channel,End User,Type,Drug Type,Dosage Form,Route of Administration,Population Type,Products.
Austria Medication Assisted Therapy (MAT) Market was valued at USD 38.30(Revenue in ) in 2020.
Austria Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 9.05% during the forecast period of 2024 to 2032.
The estimated market value of the Austria Medication Assisted Therapy (MAT) Market for final year is USD 60.49 ().
Austria Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Austria Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Distribution Channel,End User,Type,Drug Type,Dosage Form,Route of Administration,Population Type,Products.
Austria Medication Assisted Therapy (MAT) Market was valued at USD 38.30(Revenue in ) in 2020.
Austria Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 9.05% during the forecast period of 2024 to 2032.
The estimated market value of the Austria Medication Assisted Therapy (MAT) Market for final year is USD 60.49 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.